Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing. | Cell Commun Signal | 2023 | 38102645 | PubTator, text mining | PubMed |
| Targeting AKT induced Ferroptosis through FTO/YTHDF2-dependent GPX4 m6A methylation up-regulating and degradating in colorectal cancer. | Cell Death Discov | 2023 | 38102129 | PubTator, text mining | PubMed |
| Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance. | Clin Epigenetics | 2023 | 38098098 | PubTator, text mining | PubMed |
| Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer. | BMC Genomics | 2023 | 38097948 | PubTator, text mining | PubMed |
| Transcriptome-wide N6-methyladenosine methylation profile of atherosclerosis in mice. | BMC Genomics | 2023 | 38097926 | PubTator, text mining | PubMed |
| Retracted: ALKBH5 Is Lowly Expressed in Esophageal Squamous Cell Carcinoma and Inhibits the Malignant Proliferation and Invasion of Tumor Cells. | Comput Math Methods Med | 2023 | 38094422 | PubTator, text mining | PubMed |
| The role of m6A demethylases in lung cancer: diagnostic and therapeutic implications. | Front Immunol | 2023 | 38094306 | PubTator, text mining | PubMed |
| CircRNA and ferroptosis in human disease: Insights for new treatments. | Animal Model Exp Med | 2023 | 38093404 | PubTator, text mining | PubMed |
| Hypoxia induces hepatocellular carcinoma metastasis via the HIF-1α/METTL16/lnc-CSMD1-7/RBFOX2 axis. | iScience | 2023 | 38089592 | PubTator, text mining | PubMed |
| A positive feedback circuit driven by m6A-modified circular RNA facilitates colorectal cancer liver metastasis. | Mol Cancer | 2023 | 38087322 | PubTator, text mining | PubMed |
| Construction of a ceRNA regulatory network to explore potential pathogenesis mechanisms involved in human hepatocellular carcinoma. | Sci Rep | 2023 | 38086834 | PubTator, text mining | PubMed |
| FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer. | Clin Transl Med | 2023 | 38082402 | PubTator, text mining | PubMed |
| circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma. | Clin Transl Med | 2023 | 38073586 | PubTator, text mining | PubMed |
| Role of N6-methyladenosine methylation in glioma: recent insights and future directions. | Cell Mol Biol Lett | 2023 | 38072944 | PubTator, text mining | PubMed |
| The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses. | J Transl Med | 2023 | 38071304 | PubTator, text mining | PubMed |
| Unlocking the EGFR-mediated epitranscriptome: A pathway to novel therapies. | Mol Cell | 2023 | 38065059 | PubTator, text mining | PubMed |
| METTL3/YTHDC1-medicated m6A modification of circRNA3634 regulates the proliferation and differentiation of antler chondrocytes by miR-124486-5-MAPK1 axis. | Cell Mol Biol Lett | 2023 | 38062349 | PubTator, text mining | PubMed |
| GATA6-AS1 suppresses epithelial-mesenchymal transition of pancreatic cancer under hypoxia through regulating SNAI1 mRNA stability. | J Transl Med | 2023 | 38057853 | PubTator, text mining | PubMed |
| m6A modification patterns are associated with copy number burden and tumor immune landscape in thyroid cancer. | BMC Endocr Disord | 2023 | 38057752 | PubTator, text mining | PubMed |
| Overexpression of TMEM150A in glioblastoma multiforme patients correlated with dismal prognoses and compromised immune statuses. | PLoS One | 2023 | 38055673 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=33